Program
Yellow Fever Vaccine
Also written as “Yellow fever vaccine (produced on serum-free Vero cells)”, “Yellow fever vaccine (live)” and “Yellow Fever vaccine”.
Its studies are mostly in Yellow Fever · Measles · Severe Dengue · Malaria · Streptococcal Infections, led by 4 companies.
Drug pageYellow Fever Vaccine: every studyAll 25 studies of it, academic ones too, with its approvals, label and forms.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Sanofiits history only | 62 open or running | phase 3since Sep 7, 2011 | Sep 21, 2009 | none ahead |
| GlaxoSmithKline | 30 open or running | phase 3since Feb 23, 2016 | Dec 2, 2010 | none ahead |
| Novartisits history only | 10 open or running | phase 3since Nov 3, 2011 | Nov 3, 2011 | none ahead |
| Sinopharmits history only | 10 open or running | phase 3since Apr 30, 2024 | Apr 30, 2024 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of GlaxoSmithKline only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Dec 2, 2010First study: phase 2 study in Streptococcal InfectionsFirst studyNCT01262872 · 1,320 enrolled · Gambia
- Feb 23, 2016Phase 3 study in MalariaNCT02699099 · 699 enrolled · Ghana
- Dec 19, 2023Phase 2 study in Salmonella InfectionsNCT06213506 · 180 enrolled · Ghana
TargetBeta
A vaccine: it acts on a pathogen, not a human gene.
Studies
All 3 GlaxoSmithKline leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT06213506Salmonella Infections · Ghana | 2 | Completed | Aug 6, 2026 | 180 |
| NCT02699099Malaria · Ghana | 3 | Completed | Mar 14, 2018 | 699 |
| NCT01262872Streptococcal Infections · Gambia | 2 | Completed | Mar 18, 2013 | 1,320 |
How it is read
Names in the registry
- “Yellow fever vaccine (produced on serum-free Vero cells)”, 2 entries
- “Yellow fever vaccine (live)”, 2 entries
- “Yellow Fever Vaccine”, 2 entries
- “Yellow Fever vaccine”, 1 entry
- “YF vaccine (live)”, 1 entry
Conditions, from the studies’ own filings
- Yellow Fever, 4 studies
- Measles, 1 study
- Severe Dengue, 1 study
- Malaria, 1 study
- Streptococcal Infections, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.